Outcomes of hematologic malignancy patients with SARS-CoV-2 breakthrough infections after tixagevimab-cilgavimab during community transmission of monoclonal antibody resistant variants

被引：3
|
作者：
Kamboj, Mini [1 ,2 ,3 ,5 ]
Laracy, Justin C. [1 ,2 ,3 ,5 ]
Usiak, Shauna [1 ]
Babady, N. Esther [2 ,4 ]
Yan, Judy [1 ]
Seo, Susan K. [2 ,3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Infect Control, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY USA
[3] Weill Cornell Med Coll, Dept Med, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, Clin Microbiol Serv, New York, NY USA
[5] 1275 York Ave, New York, NY 10065 USA
来源：
JOURNAL OF INFECTION | 2023年 / 87卷 / 03期
关键词：
D O I：
10.1016/j.jinf.2023.06.024
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：282 / 285
页数：4
相关论文
共 50 条
  • [41] Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages era
    Vergori, Alessandra
    Lepri, Alessandro Cozzi
    Chiuchiarelli, Marta
    Mazzotta, Valentina
    Metafuni, Elisabetta
    Matusali, Giulia
    Siciliano, Valentina
    Paulicelli, Jessica
    Alma, Eleonora
    Siniscalchi, Agostina
    Sica, Simona
    Abruzzese, Elisabetta
    Fantoni, Massimo
    Antinori, Andrea
    Cingolani, Antonella
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2024, 144
  • [42] Tixagevimab and Cilgavimab Administration for Hemodialysis Patients at Community-Based Dialysis Centers in Singapore as Pre-Exposure Prophylaxis for SARS-CoV-2 Infection
    Khan, Behram A.
    Pagsinohin, Marlyn
    Lu, Lucy M.
    Tan, Pauline
    Teo, Rachel
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [43] Outcomes Following Community-Acquired SARS-CoV-2 Infections for Patients with BPD
    Ingram, M.
    Miller, A.
    Krivchenia, K.
    Shepherd, E. G.
    Nelin, L. D.
    Kielt, M. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [44] Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections
    Selva, Kevin J.
    Ramanathan, Pradhipa
    Haycroft, Ebene R.
    Reynaldi, Arnold
    Cromer, Deborah
    Tan, Chee Wah
    Wang, Lin-Fa
    Wines, Bruce D.
    Hogarth, P. Mark
    Downie, Laura E.
    Davis, Samantha K.
    Purcell, Ruth A.
    Kent, Helen E.
    Juno, Jennifer A.
    Wheatley, Adam K.
    Davenport, Miles P.
    Kent, Stephen J.
    Chung, Amy W.
    JCI INSIGHT, 2023, 8 (18)
  • [45] Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections
    Terreri, Sara
    Mortari, Eva Piano
    Vinci, Maria Rosaria
    Russo, Cristina
    Alteri, Claudia
    Albano, Christian
    Colavita, Francesca
    Gramigna, Giulia
    Agrati, Chiara
    Linardos, Giulia
    Coltella, Luana
    Colagrossi, Luna
    Deriu, Gloria
    Degli Atti, Marta Ciofi
    Rizzo, Caterina
    Scarsella, Marco
    Brugaletta, Rita
    Camisa, Vincenzo
    Santoro, Annapaola
    Roscilli, Giuseppe
    Pavoni, Emiliano
    Muzi, Alessia
    Magnavita, Nicola
    Scutari, Rossana
    Villani, Alberto
    Raponi, Massimiliano
    Locatelli, Franco
    Perno, Carlo Federico
    Zaffina, Salvatore
    Carsetti, Rita
    CELL HOST & MICROBE, 2022, 30 (03) : 400 - +
  • [46] Early administration of SARS-CoV-2 monoclonal antibody reduces the risk of mortality in hematologic malignancy and hematopoietic cell transplant patients with COVID-19
    Jabr, Ra'ed
    Khatri, Akshay
    Anderson, Anthony D.
    Garcia, Leopoldo Cordova
    Viotti, Julia Bini
    Natori, Yoichiro
    Raja, Mohammed
    Camargo, Jose F.
    Morris, Michele I.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (01)
  • [47] Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants
    Mizoue, Tetsuya
    Yamamoto, Shohei
    Konishi, Maki
    Oshiro, Yusuke
    Inamura, Natsumi
    Nemoto, Takashi
    Ozeki, Mitsuru
    Horii, Kumi
    Okudera, Kaori
    Sugiyama, Haruhito
    Aoyanagi, Nobuyoshi
    Sugiura, Wataru
    Ohmagari, Norio
    JOURNAL OF INFECTION, 2022, 85 (05) : 585 - 586
  • [48] SARS-CoV-2 variants resistant to monoclonal antibodies in immunocompromised patients constitute a public health concern
    Casadevall, Arturo
    Focosi, Daniele
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (06):
  • [49] Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan
    Okumura, Nobumasa
    Tsuzuki, Shinya
    Saito, Sho
    Hattori, Shin-ichiro
    Takeuchi, Junko S.
    Saito, Tomoya
    Ujiie, Mugen
    Hojo, Masayuki
    Iwamoto, Noriko
    Sugiura, Wataru
    Mitsuya, Hiroaki
    Ohmagari, Norio
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (09) : 1340 - 1343
  • [50] Glucose control during breakthrough SARS-CoV-2 infections in vaccinated patients with type 1 diabetes
    Longo, Miriam
    Scappaticcio, Lorenzo
    Signoriello, Simona
    Caruso, Paola
    Maio, Antonietta
    Botta, Graziella
    Arena, Stefania
    Cirillo, Paolo
    Petrizzo, Michela
    Bellastella, Giuseppe
    Maiorino, Maria Ida
    Chiodini, Paolo
    Esposito, Katherine
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 207
12345